Trials / Completed
CompletedNCT00357916
Study to Determine the Sensitizing Potential of PEP005 Topical Gel in Healthy Volunteers Using a Repeat Insult Patch Test Design
A Randomized, Controlled Study to Evaluate the Sensitizing Potential of PEP005 Topical Gel (0.01% Concentration) in Healthy Volunteers Using a Repeat Insult Patch Test Design
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 200 (planned)
- Sponsor
- Peplin · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
To determine the sensitisation potential of PEP005 Topical Gel (0.01% concentration) on normal skin To evaluate skin irritation
Detailed description
This is a repeat insult patch test study. On treatment days, the investigational product PEP005 Topical Gel (0.01% concentration) and vehicle control will be applied under open conditions to sites on the infrascapular region of the back 3 times weekly for 3 weeks (9 applications in total) during the induction phase. Following a rest period of approximatley 10-14 days, a single challenge application will be performed. Local tolerability will be assessed visually using an ordinal scoring system. If a cutaneous response observed in the challenge phase indicates possible sensitisation, or at the discretion of the investigator, a rechallenge will occur
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | PEP005 Topical Gel (0.01% concentration) |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2006-10-01
- Completion
- 2006-10-01
- First posted
- 2006-07-28
- Last updated
- 2016-04-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00357916. Inclusion in this directory is not an endorsement.